US FDA approves Mainstay Medical's ReActiv8 product

·

·

US FDA approves Mainstay Medical's ReActiv8 product

Dublin listed medical device company Mainstay Medical said today that the US Food and Drug Administration (FDA) has approved its Premarket Approval (PMA) application for its ReActiv8 product. ReActiv8 is a device Mainstay has developed to treat chronic …
See Original Article

Mid-tier relaunches financial reporting division

William Buck has relaunched its financial reporting accounting and advisory service in a bid to help businesses deal with regulatory changes, tax
See Original Article

Indian stocks rise as approvals to make COVID-19 drugs boost pharma shares

BENGALURU, June 22 (Reuters) – Indian shares rose on Monday as domestic regulatory approvals to manufacture COVID-19 drugs lifted pharmaceutical stocks, countering the impact of another surge in coronavirus cases over the weekend. The NSE Nifty …
See Original Article

Asian Shares Mixed as US Reports Surging Virus Cases

BANGKOK (AP) — Shares were mixed Monday in Asia as China and South Korea reported lower numbers of new coronavirus cases, while new infections in the U.S. and worldwide surged sharply. Tokyo, Hong Kong and Seoul declined while Shanghai …
See Original Article

Checkout.com triples valuation to $5.5 billion, making it one of Europe's top fintechs

Checkout.com has seen its valuation almost triple in a Series B funding round led by technology-focused hedge fund Coatue. The start-up has achieved impressive growth over the last year, increasing transaction volumes by 250% and picking up big-name …
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.